Passa al contenuto
Merck
  • Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital.

Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital.

The new microbiologica (2014-02-18)
Paolo Gaibani, Rosaria Colombo, Milena Arghittu, Lisa Cariani, Simone Ambretti, Gloria Bua, Donatella Lombardo, Maria Paola Landini, Erminio Torresani, Vittorio Sambri
ABSTRACT

We describe an outbreak of a carbapenemase-producing Klebsiella pneumoniae sequence type 258 (ST258) clone in an Italian hospital during two months in 2010. The rapid detection and management of the eleven patients colonized and infected with KPC-producing K.pneumoniae curbed the spread of this multidrug-resistant organism.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Penicillinasi, lyophilized powder, 1,500-3,000 units/mg protein (using benzylpenicillin)
Sigma-Aldrich
β-Lactamase, recombinant, expressed in E. coli
Sigma-Aldrich
β-Lactamase from Enterobacter cloacae, Type IV, lyophilized powder, 0.2-0.6 units/mg protein (using benzylpenicillin)
Sigma-Aldrich
β-Lactamase Blend, recombinant, expressed in E. coli
Sigma-Aldrich
Penicillinasi, lyophilized, powder, white, ~13 U/mg
Sigma-Aldrich
β-Lactamase from Pseudomonas fluorescens, lyophilized powder, recombinant, expressed in E. coli